Menu

Drugmaker Tolmar said it will refund 340B covered entities for overcharges on certain generic dermatologic products.

Tolmar Providing Refunds for Five Years of 340B Overcharges

September 6, 2023 Tom Mirga, Editor at Large 340B Report Views

Drug manufacturer Tolmar recently said it plans refunds to 340B covered entities for overcharges on seven generic dermatologic products purchased [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Five Value Pillars for 340B Program Compliance

PhRMA to Federal Appeals Court: Arkansas Enforcing 340B Contract Pharmacy Law; Seventh Drugmaker Sues Over IRA